Founded in 1890, Santen has contributed to improving the quality of life of patients all over the world with its rich experience in the field of ophthalmology.
While developing internal pipelines, Santen is well aware of the importance of cooperating with other companies, research centers and universities, placing significant emphasis on strengthening the relationships with our partners. We are always committed to working with external partners.
Our world-class research & development centers, manufacturing sites and sales & marketing operations allow us to deliver innovative products that bring success to each and every one of our partnerships.
Santen offers a full range of ophthalmology treatments, such as corneal and retinal diseases, glaucoma and drug delivery systems, and seeks opportunities for the diseases and technologies listed below to enhance our portfolio.
Other corneal diseases
Age-related macular degeneration (wet/dry)
Other retinal diseases
Drug delivery system